Skip to main content

Table 2 Plasma sPLA2-IIa levels and diagnosis in patients with benign SPNs from BNLCC

From: Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules

Sample sPLA2-IIa (pg/ml) Diagnosis
1 1039.2 0.9 cm nodule and heavy smoker
2 1589.2 1.3 × 1.4 × 1.1 cm subpleural nodule, necrotizing granuloma
3 480.83 Nodule 2 cm
4 8980.8 Necrotizing granulomatous
5 1030.8 Nonnecrotizing granulomas
6 1105.8 Abscess colonized with fungal hyphae
7 3680.8 Nodule with organizing pneumonia pattern of lung injury
8 922.5 Caseating granulomas with emphysematous changes
9 797.5 Nodules of caseating granulomas
10 2372.5 Necrotizing granuloma with fungal organisms
11 1789.2 Peribronchial tumorlet-2 mm and focal parenchymal fibrosis
12 580.83 Necrotizing granuloma with fungal organisms
13 2305.8 Necrotizing granuloma (2 × 1.7 × 1.3 cm)
14 872.5 Broncial and broncheolar ectasis with fibrosis and chronic inflammation c/w bronchiectasis
15 2714.2 Bronchiolitis obliterans organizing pneumonia
16 714.17 Focal fibrosis and chronic inflammation and reactive pneumocyte hyperplasia
17 2105.8 Caseating granulomas with fungal elements
18 2422.17 Myolipomatous polyp
19 1226.52 Active granulomatous inflammation and possible sarcoidosis
20 2217.83 Neurofibroma, 4.5 × 3.5 cm
21 1804.78 Active non-caseating granulomas
22 430.87 Necrotizing granuloma with fungal organisms
23 3878.7 Caseating necrotizing granulomas with fungal elements
24 835.22 Non-caseating granulomas with fungal elements
25 572.5 Necrotizing granulomatous inflammation with fungal organisms consistent with Aspergillus
26 1553.75 Necrotizing granulomas with fungal yeast forms consistent with Histoplasma
27 816.25 Organizing suppurative bronchopneumonia with pleural adhesions
28 1328.75 Presented with sTable lung nodule
29 1228.13 necrotizing granuloma and Langerhans' cell histiocytosis
  1. *The data in bold is higher than the cutoff value of the blood test.